The approval is based on a trial that revealed that the system’s treatment led to improvements in disability and pain.

The lumbar degenerative disc disease market is projected to demonstrate substantial growth in the coming years across the 7MM. The market landscape is witnessing active participation from key ...

As the world’s population ages, intervertebral disc degeneration (IDD) has become a major medical issue, causing chronic lower back pain and mobility issues that diminish the quality of life for ...

ReGelTec Inc., a company developing a percutaneous hydrogel implant for the treatment of chronic low back pain caused by ...

Chronic low back pain associated with intervertebral disc degeneration remains a significant clinical challenge, particularly for patients who do not respond to conservative treatment. Discogenic ...

When it’s required, the donor NP is reconstituted with 2 ml of sterile saline and injected into the degenerated intervertebral disc (or discs). The procedure is done while the patient is awake ...

A single intradiscal injection of allogeneic NP reduced chronic lumbar discogenic pain and improved function at 12 months, ...

While she ended her 2022 prematurely and did her best to fully recover, it didn't happen. In the end, she was diagnosed with a lumbar disc degeneration in her back. Shortly after the diagnosis, ...